Education
About Us
Working with TipRanks
Follow Us
Enorama Pharma AB (SE:ERMA)
:ERMA
ERMA Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr1.52 - kr8.48
Previous CloseN/A
Volume29.79K
Average Volume (3M)11.42K
Market Cap
kr162.67M
Enterprise ValueN/A
Total Cash (Recent Filing)kr2.08M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Aug 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding60,473,297
10 Day Avg. Volume14,282
30 Day Avg. Volume11,417
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)18.60
Price to Sales (P/S)0.00
P/FCF Ratio-4.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ERMA FAQ
What was Enorama Pharma AB’s price range in the past 12 months?
Enorama Pharma AB lowest stock price was kr1.51 and its highest was kr8.48 in the past 12 months.
What is Enorama Pharma AB’s market cap?
Enorama Pharma AB’s market cap is kr162.67M.
When is Enorama Pharma AB’s upcoming earnings report date?
Enorama Pharma AB’s upcoming earnings report date is Aug 20, 2025 which is in 82 days.
How were Enorama Pharma AB’s earnings last quarter?
Enorama Pharma AB released its earnings results on May 21, 2025. The company reported -kr0.372 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.372.
Is Enorama Pharma AB overvalued?
According to Wall Street analysts Enorama Pharma AB’s price is currently Overvalued.
Does Enorama Pharma AB pay dividends?
Enorama Pharma AB does not currently pay dividends.
What is Enorama Pharma AB’s EPS estimate?
Enorama Pharma AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enorama Pharma AB have?
Enorama Pharma AB has 60,473,297 shares outstanding.
What happened to Enorama Pharma AB’s price movement after its last earnings report?
Enorama Pharma AB reported an EPS of -kr0.372 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.115%.
Which hedge fund is a major shareholder of Enorama Pharma AB?
Currently, no hedge funds are holding shares in SE:ERMA
Technical Analysis
Vivesto AB
―
Elicera Therapeutics AB
―
Active Biotech AB
―
NextCell Pharma AB
―
Bio-Works Technologies AB
―